RxSight (RXST) Assets (2020 - 2026)

RxSight (RXST) has 7 years of Assets data on file, last reported at $304.0 million in Q1 2026.

• For the quarter ending Q1 2026, Assets fell 2.89% year-over-year to $304.0 million; the trailing twelve-month figure through Mar 2026 stood at $304.0 million (down 2.89% YoY), and the FY2025 full-year result was $311.8 million, down 2.12% from the prior year.
• Assets for Q1 2026 stood at $304.0 million, down from $311.8 million in the prior quarter.
• Across five years, Assets topped out at $318.6 million in Q4 2024 and bottomed at $150.2 million in Q4 2022.
• The 5-year median for Assets is $202.5 million (2023), against an average of $239.8 million.
• Peak annual rise in Assets reached 75.7% in 2022, while the deepest fall reached 23.57% in 2022.
• A 5-year view of Assets shows it stood at $150.2 million in 2022, then increased by 21.57% to $182.5 million in 2023, then jumped by 74.51% to $318.6 million in 2024, then dropped by 2.12% to $311.8 million in 2025, then declined by 2.51% to $304.0 million in 2026.
• The last three Assets figures came in at $304.0 million (Q1 2026), $311.8 million (Q4 2025), and $308.5 million (Q3 2025), per Business Quant data.

Peer Comparison